{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:13:22Z","timestamp":1791724402138,"version":"4.3.4"},"reference-count":55,"publisher":"American Chemical Society (ACS)","issue":"26","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFA0502301"],"award-info":[{"award-number":["2016YFA0502301"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573350"],"award-info":[{"award-number":["81573350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The replica exchange molecular dynamics (REMD) simulation is demonstrated to readily predict the conformations of the macrocyclic drug lorlatinib, as validated by solution NMR studies. In aqueous solution, lorlatinib adopts a conformer identical to its target bound structure. This conformer is stabilized by an extensive hydrogen bond network to the solvents. In chloroform, lorlatinib populates two conformers with the second one being less polar, which may contribute to lorlatinib\u2019s ability to cross cell membranes.<\/jats:p>","DOI":"10.1021\/acsomega.9b03797","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T07:29:36Z","timestamp":1576481376000},"page":"22245-22250","source":"Crossref","is-referenced-by-count":20,"title":["Conformation of\nthe Macrocyclic Drug Lorlatinib in\nPolar and Nonpolar Environments: A MD Simulation and NMR Study"],"prefix":"10.1021","volume":"4","author":[{"given":"Cheng","family":"Peng","sequence":"first","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zuchongzhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , No.19A Yuquan Road , ,","place":["Beijing, China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoseph","family":"Atilaw","sequence":"additional","affiliation":[{"name":"Uppsala University , , Box 576, ,","place":["Uppsala, Sweden, SE-751 23"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zuchongzhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3063-8473","authenticated-orcid":true,"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zuchongzhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , No.19A Yuquan Road , ,","place":["Beijing, China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8880-9247","authenticated-orcid":true,"given":"Vasanthanathan","family":"Poongavanam","sequence":"additional","affiliation":[{"name":"Uppsala University , , Box 576, ,","place":["Uppsala, Sweden, SE-751 23"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Shi","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zuchongzhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4205-6040","authenticated-orcid":true,"given":"Jan","family":"Kihlberg","sequence":"additional","affiliation":[{"name":"Uppsala University , , Box 576, ,","place":["Uppsala, Sweden, SE-751 23"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-5299","authenticated-orcid":true,"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zuchongzhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , No.19A Yuquan Road , ,","place":["Beijing, China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0301te\u0301","family":"Erde\u0301lyi","sequence":"additional","affiliation":[{"name":"Uppsala University , , Box 576, ,","place":["Uppsala, Sweden, SE-751 23"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2026091508264685100_cit1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/jm400887j","article-title":"Macrocyclic drugs and clinical candidates: what can\nmedicinal chemists learn from their properties?","volume":"57","author":"Giordanetto","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nchembio.1584","article-title":"How proteins bind macrocycles","volume":"10","author":"Villar","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"2026091508264685100_cit3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/acs.jmedchem.5b01286","article-title":"How Beyond Rule of\n5 Drugs and Clinical Candidates Bind to Their Targets","volume":"59","author":"Doak","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and\ncomputational approaches to estimate solubility and permeability in\ndrug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv.\nDrug Delivery Rev."},{"key":"2026091508264685100_cit5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.4155\/fmc.12.93","article-title":"Macrocycles in new\ndrug discovery","volume":"4","author":"Mallinson","year":"2012","journal-title":"Future Med. Chem."},{"key":"2026091508264685100_cit6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrd2590","article-title":"The exploration\nof macrocycles for drug discovery \u2500an underexploited structural\nclass","volume":"7","author":"Driggers","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091508264685100_cit7","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1021\/ja0563455","article-title":"Testing\nthe conformational hypothesis of passive membrane permeability using\nsynthetic cyclic peptide diastereomers","volume":"128","author":"Rezai","year":"2006","journal-title":"J. Am.\nChem. Soc."},{"key":"2026091508264685100_cit8","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1039\/c1ob05996c","article-title":"Comparison\nof diffusion coefficients\nfor matched pairs of macrocyclic and linear molecules over a drug-like\nmolecular weight range","volume":"9","author":"Bogdan","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"2026091508264685100_cit9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact\nof natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2026091508264685100_cit10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ddtec.2018.06.008","article-title":"Macrocycles:\nMCR synthesis and applications\nin drug discovery","volume":"29","author":"Abdelraheem","year":"2018","journal-title":"Drug Discovery Today: Technol."},{"key":"2026091508264685100_cit11","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1021\/jo2011494","article-title":"Synthesis of vaniprevir\n(MK-7009): lactamization to\nprepare a 22-membered macrocycle","volume":"76","author":"Song","year":"2011","journal-title":"J. Org. Chem."},{"key":"2026091508264685100_cit12","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1021\/jm400164c","article-title":"Discovery of danoprevir (ITMN-191\/R7227),\na highly selective and potent inhibitor of hepatitis C virus (HCV)\nNS3\/4A protease","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit13","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1021\/jm500261q","article-title":"Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile\n(PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase\n(ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure\nand broad-spectrum potency against ALK-resistant mutations","volume":"57","author":"Johnson","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit14","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/jm1012374","article-title":"Macrocycles are\ngreat cycles: applications, opportunities,\nand challenges of synthetic macrocycles in drug discovery","volume":"54","author":"Marsault","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule\ninhibitors of protein-protein\ninteractions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"key":"2026091508264685100_cit16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big\ntargets: drug discovery faces the protein\u2013protein\ninteraction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091508264685100_cit17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1021\/acsmedchemlett.7b00219","article-title":"Artificial\nMacrocycles as Potent p53\u2013MDM2 Inhibitors","volume":"8","author":"Estrada-Ortiz","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"2026091508264685100_cit18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis\ndiscoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091508264685100_cit19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1039\/C7MD00464H","article-title":"Artificial Macrocycles as IL-17A\/IL-17RA\nAntagonists","volume":"9","author":"Wang","year":"2018","journal-title":"Medchemcomm"},{"key":"2026091508264685100_cit20","doi-asserted-by":"publisher","first-page":"10386","DOI":"10.1039\/C6OB01510G","article-title":"Flexibility is important\nfor inhibition of the MDM2\/p53 protein\u2013protein interaction\nby cyclic \u03b2-hairpins","volume":"14","author":"Danelius","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"2026091508264685100_cit21","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1021\/ja064863p","article-title":"Relationship\namong ligand conformations in solution, in the solid state, and at\nthe Hsp90 binding site: geldanamycin and radicicol","volume":"129","author":"Thepchatri","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"2026091508264685100_cit22","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1021\/ja0580237","article-title":"NMR determination of the bioactive conformation of\npeloruside A bound to microtubules","volume":"128","author":"Jime\u0301nez-Barbero","year":"2006","journal-title":"J. Am. Chem.\nSoc."},{"key":"2026091508264685100_cit23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0014-5793(94)80149-5","article-title":"The 3D structure of\na cyclosporin analogue in water\nis nearly identical to the cyclophilin-bound cyclosporin conformation","volume":"340","author":"Wenger","year":"1994","journal-title":"FEBS Lett."},{"key":"2026091508264685100_cit24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.1566062","article-title":"A conformation of cyclosporin A in\naqueous environment revealed by the X-ray structure of a cyclosporin-Fab\ncomplex","volume":"256","author":"Altschuh","year":"1992","journal-title":"Science"},{"key":"2026091508264685100_cit25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/jm7013452","article-title":"Conformational preferences of natural\nand C3-modified epothilones in aqueous solution","volume":"51","author":"Erde\u0301lyi","year":"2008","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit26","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1021\/acs.jmedchem.8b00347","article-title":"Impact of Dynamically Exposed Polarity on Permeability\nand Solubility of Chameleonic Drugs Beyond the Rule of 5","volume":"61","author":"Rossi Sebastiano","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026091508264685100_cit27","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nchembio.2203","article-title":"Structural and conformational determinants\nof macrocycle cell permeability","volume":"12","author":"Over","year":"2016","journal-title":"Nat. Chem.\nBiol."},{"key":"2026091508264685100_cit28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.drudis.2016.02.005","article-title":"Quantifying the chameleonic\nproperties of macrocycles and other high-molecular-weight\ndrugs","volume":"21","author":"Whitty","year":"2016","journal-title":"Drug Discovery Today"},{"key":"2026091508264685100_cit29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.drudis.2007.11.007","article-title":"Assessing drug-likeness--what\nare\nwe missing?","volume":"13","author":"Vistoli","year":"2008","journal-title":"Drug Discovery Today"},{"key":"2026091508264685100_cit30","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1021\/ci900238a","article-title":"Conformational\nAnalysis\nof Macrocycles: Finding What Common Search Methods Miss","volume":"49","author":"Bonnet","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit31","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1021\/ci300314k","article-title":"Conformer\ngeneration with OMEGA: learning from the\ndata set and the analysis of failures","volume":"52","author":"Hawkins","year":"2012","journal-title":"J. Chem.\nInf. Model."},{"key":"2026091508264685100_cit32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/ci900508k","article-title":"LowModeMD-Implicit\nLow-Mode Velocity Filtering Applied to Conformational Search of Macrocycles\nand Protein Loops","volume":"50","author":"Labute","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit33","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1021\/ci5001696","article-title":"Macrocycle\nconformational sampling with MacroModel","volume":"54","author":"Watts","year":"2014","journal-title":"J.\nChem. Inf. Model."},{"key":"2026091508264685100_cit34","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1021\/acs.jctc.6b00250","article-title":"Exhaustive\nConformational Sampling of Complex Fused Ring Macrocycles Using Inverse\nKinematics","volume":"12","author":"Coutsias","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"2026091508264685100_cit35","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1021\/acs.jcim.6b00237","article-title":"Dihedral Angle-Based Sampling of Natural Product Polyketide\nConformations: Application to Permeability Prediction","volume":"56","author":"Wang","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit36","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.1016\/j.bmc.2013.10.003","article-title":"Tackling the conformational sampling of larger flexible\ncompounds and macrocycles in pharmacology and drug discovery","volume":"21","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"2026091508264685100_cit37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/acs.jcim.6b00443","article-title":"Docking of\nMacrocycles: Comparing Rigid and Flexible Docking in Glide","volume":"57","author":"Alogheli","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit38","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1021\/acs.jcim.7b00052","article-title":"Improving Accuracy,\nDiversity, and Speed with Prime\nMacrocycle Conformational Sampling","volume":"57","author":"Sindhikara","year":"2017","journal-title":"J. Chem.\nInf. Model."},{"key":"2026091508264685100_cit39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1021\/acs.jcim.8b00097","article-title":"Peptidic\nMacrocycles\u2013Conformational Sampling and Thermodynamic Characterization","volume":"58","author":"Kamenik","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit40","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1021\/acs.jctc.8b00657","article-title":"CoCo-MD:\nA Simple and Effective Method for the Enhanced\nSampling of Conformational Space","volume":"15","author":"Shkurti","year":"2019","journal-title":"J. Chem. Theory\nComput."},{"key":"2026091508264685100_cit41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA:\nalgorithm and validation\nusing high quality structures from the Protein Databank and Cambridge\nStructural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"2026091508264685100_cit42","doi-asserted-by":"publisher","first-page":"11742","DOI":"10.1021\/acsomega.8b01379","article-title":"Conformational Sampling of Macrocyclic\nDrugs in Different Environments: Can We Find the Relevant Conformations?","volume":"3","author":"Poongavanam","year":"2018","journal-title":"ACS Omega"},{"key":"2026091508264685100_cit43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics\nsimulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"2026091508264685100_cit44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.carbpol.2015.10.018","article-title":"Conformation\nstudy of \u03b5 -cyclodextrin: Replica exchange molecular dynamics\nsimulations","volume":"141","author":"Khuntawee","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"2026091508264685100_cit45","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1021\/acs.jpclett.6b00452","article-title":"Accurate Structure\nPrediction and\nConformational Analysis of Cyclic Peptides with Residue-Specific Force\nFields","volume":"7","author":"Geng","year":"2016","journal-title":"J. Phys. Chem. Lett."},{"key":"2026091508264685100_cit46","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1073\/pnas.1420785112","article-title":"PF-06463922\nis a potent and selective next-generation ROS1\/ALK inhibitor capable\nof blocking crizotinib-resistant ROS1 mutations","volume":"112","author":"Zou","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026091508264685100_cit47","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejmech.2017.04.032","article-title":"First macrocyclic 3(rd)-generation\nALK inhibitor for treatment of ALK\/ROS1 cancer: Clinical and designing\nstrategy update of lorlatinib","volume":"134","author":"Basit","year":"2017","journal-title":"Eur. J. Med.\nChem."},{"key":"2026091508264685100_cit48","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1002\/anie.201509240","article-title":"Conformational\nStudies and Atropisomerism Kinetics\nof the ALK Clinical Candidate Lorlatinib (PF-06463922) and Desmethyl\nCongeners","volume":"55","author":"Elleraas","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026091508264685100_cit49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1508887","article-title":"Resensitization\nto Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F","volume":"374","author":"Shaw","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2026091508264685100_cit50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.bpj.2013.02.011","article-title":"Nanoscale Measurement\nof the Dielectric Constant of\nSupported Lipid Bilayers in Aqueous Solutions with Electrostatic Force\nMicroscopy","volume":"104","author":"Gramse","year":"2013","journal-title":"Biophys. J."},{"key":"2026091508264685100_cit51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1021\/ja00108a019","article-title":"NMR Analysis of Molecular\nFlexibility\nin Solution: A New Method for the Study of Complex Distributions of\nRapidly Exchanging Conformations. Application to a 13-Residue Peptide\nwith an 8-Residue Loop","volume":"117","author":"Cicero","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"2026091508264685100_cit52","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1021\/jo9824450","article-title":"A Test of the Single-Conformation\nHypothesis in the Analysis of NMR Data for Small Polar Molecules:\nA Force Field Comparison","volume":"64","author":"Nevins","year":"1999","journal-title":"J. Org. Chem."},{"key":"2026091508264685100_cit53","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1055\/s-0033-1339670","article-title":"Insight into \u03b2-Hairpin Stability:\nInterstrand Hydrogen Bonding","volume":"24","author":"Danelius","year":"2013","journal-title":"Synlett"},{"key":"2026091508264685100_cit54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1093-3263(02)00123-7","article-title":"VEGA: a versatile program\nto convert,\nhandle and visualize molecular structure on Windows-based PCs","volume":"21","author":"Pedretti","year":"2002","journal-title":"J. Mol. Graphics Modell."},{"key":"2026091508264685100_cit55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00119860","article-title":"Molecular\nlipophilicity\npotential, a tool in 3D QSAR: method and applications","volume":"8","author":"Gaillard","year":"1994","journal-title":"J. Comput.-Aided Mol. Des."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.9b03797","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/4\/26\/22245\/68301357\/acsomega.9b03797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/4\/26\/22245\/68301357\/acsomega.9b03797.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:43:22Z","timestamp":1789476202000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/4\/26\/22245\/608541\/Conformation-of-the-Macrocyclic-Drug-Lorlatinib-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":55,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2019,12,16]]},"published-print":{"date-parts":[[2019,12,24]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.9b03797","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]}}}